doi:10.3803/enm.2019.34.3.247
Glucagon-like peptide-1: a potent regulator of food intake in humans
Theyre featured in ads, celebrity headlines, friends anecdotes and endless online takes
For GLP-1, the review confirmed insulinotropic effects on -cells during hyperglycaemia, glucagonostatic effects on -cells during hyperglycaemia (indirect, via somatostatin and insulin), gastric emptying delay, CNS appetite suppression, and indirect promotion of lipolysis via increased sympathetic activity
Your comfort and safety remain our priority throughout the entire weight loss process
While mild to moderate nausea is expected with GLP-1 therapy, certain symptoms warrant prompt medical evaluation